About Heal Capital
Heal Capital is a venture capital firm founded in 2019. It is primarily based out of Berlin, Germany. As of May 2026, Heal Capital is an active investor, having invested in 28 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in Germany based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Series A round of Ditto Care Overall, Heal Capital portfolio has seen 3 acquisitions, namely Gleamer, Siilo and FORMEL Skin. A lot of funds co-invest with Heal Capital, with names like Octopus Ventures sharing a substantial percentage of its portfolio. Heal Capital has team of 7 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Heal Capital's List of Top Investments
Heal Capital has a portfolio of 28 companies. Their most notable investments are in Formly.ai and Actio.Their portfolio spans across Germany, United Kingdom, France and 6 more locations. They have invested in Enterprise Applications, HealthTech, Life Sciences and 5 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Heal Capital:1. SolasCure
Developer of biologic therapies for the treatment of chronic wounds. This therapy utilizes enzymatic debridement to prepare the wound bed while activating endogenous repair pathways to facilitate healing. The treatment is designed to address biological barriers that prevent tissue regeneration in patients with persistent wounds.
Key facts about SolasCure
- Founded Year: 2017
- Location: Cambridge (United Kingdom)
- Stage: Series B
- Total Funding till date: $34.1M
- Employee Count: 17 as on May 31, 2026
- Investors: Innovate UK, IQ-EQ and 66 Others
- Latest Funding Round: Grant (prize money), Mar 20, 2024, $*****
- Highlight: Editors' Pick
AI-based tissue analysis software for surgical precision. The company has developed software that assists clinicians during medical surgery by providing computer-assisted tissue analysis technology. It has features to provide real-time tissue analysis, tissue & surgery measurement, optical imaging, AI-based quantitative imaging, and more.
Key facts about Hypervision Surgical
- Founded Year: 2020
- Location: London (United Kingdom)
- Stage: Series A
- Total Funding till date: $31M
- Employee Count: 27 as on May 31, 2026
- Investors: Redalpine, Life Extension Ventures and 10 Others
- Latest Funding Round: Series A, Apr 29, 2026, $*****
- Highlight: Editors' Pick
3. Gleamer
Developer of artificial intelligence software for medical imaging diagnostic analysis. This technology integrates with existing radiology workflows to assist in the detection and assessment of pathologies across various modalities including X-ray, computed tomography, and magnetic resonance imaging. The software provides automated measurements, worklist prioritization, and reporting assistance to support clinical image interpretation. These tools function as a gateway for deploying diagnostic algorithms that process medical data to identify abnormalities in bone, chest, breast, and neurological scans.
Key facts about Gleamer
- Founded Year: 2017
- Location: Paris (France)
- Stage: Acquired
- Total Funding till date: $40M
- Employee Count: 125 as on May 31, 2026
- Investors: Bpifrance, Supernova Invest and 10 Others
- Latest Funding Round: Series B, Jun 28, 2023, $*****
- Highlight: Acquired
4. Apheris
Provider of data analytics solutions for life science industry. The platform enables organizations to collaborate on distributed data in real time. It offers a federated computational governance solution to support data-driven analysis. The platform allows users to build federated data networks to enable hospitals, fellow researchers and other pharmaceutical innovators to build predictive models.
Key facts about Apheris
- Founded Year: 2019
- Location: Berlin (Germany)
- Stage: Series A
- Total Funding till date: $20.8M
- Employee Count: 52 as on May 31, 2026
- Investors: OTB Ventures, LocalGlobe and 16 Others
- Latest Funding Round: Series A, Jan 02, 2025, $*****
- Highlight: Editors' Pick
5. Siilo
Developer of secure messaging application and network for healthcare professionals. The application facilitates communication and care coordination among medical teams. It offers a platform for members to connect and collaborate securely. The application provides secure messaging and streamlined workflows, allowing for informed decisions.
Key facts about Siilo
- Founded Year: 2015
- Location: Amsterdam (Netherlands)
- Stage: Acquired
- Total Funding till date: $15.7M
- Employee Count: 36 as on May 31, 2026
- Investors: EQT, Philips and 3 Others
- Latest Funding Round: Series A, Jul 30, 2020, $*****
- Highlight: Acquired
Heal Capital's Year-on-Year Investment Trends
Heal Capital has invested in 28 companies over the last 6 years, with an average of 3 new investments annually in the last 5 years. In 2025, it made 6 investments, while as of May 2026, it has made 2 investments in this year. Its most recent first time investment was in Ditto Care and most recent follow-on round was in Hema.to.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 4 | 2 | 6 |
2024 | 4 | 0 | 4 |
2023 | 2 | 0 | 2 |
2022 | 2 | 3 | 5 |
2021 | 6 | 0 | 6 |
2020 | 3 | 0 | 3 |
Heal Capital's Investments by Stage
Heal Capital has made 12 investments in Seed stage with an average round size of $4.49M, 10 investments in Series A stage with an average round size of $16.2M and 1 investment in Series B stage with an average round size of $29.5M.Stage of entry | No. of Investments |
|---|---|
Seed | 12 |
Series A | 10 |
Series B | 1 |
Note: We have considered here, only first round of investments
Heal Capital's Investments by Sector
Heal Capital has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Healthcare, Artificial Intelligence - Industry Applications and Life Sciences. Notably, it has invested in 19 Tech companies, 17 Enterprise (B2B) companies, 15 Software companies and at least 5 companies focusing on Saas.Sector | No. of Investments |
|---|---|
HealthTech | 14 |
Enterprise Applications | 12 |
Healthcare | 5 |
Artificial Intelligence - Industry Applications | 4 |
Life Sciences | 4 |
Others | 10 |
Note: We have considered here, only first round of investments
Heal Capital's Investments by Geography
Heal Capital has made most investments in Germany (9), followed by United Kingdom where it has made 5 investments.Country | No. of Investments |
|---|---|
Germany | 9 |
United Kingdom | 5 |
France | 2 |
Switzerland | 2 |
United States | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
Heal Capital's recent investments
Heal Capital has made 2 investments in 2026 so far - Ditto Care and Hypervision Surgical.Here are the most recent investments by Heal Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 12, 2026 | - | Series A | 9046 | ||
Apr 29, 2026 | United Kingdom | Series A | 3267 | [+7] | |
Sep 15, 2025 | United States | Seed | 6509 | [+3] | |
Jul 02, 2025 | United Kingdom | Series A | 2269 | [+1] | |
Apr 14, 2025 | Switzerland | Seed | 1265 | [+5] |
Acquired companies in Heal Capital's Portfolio
3 companies from Heal Capital's portfolio have been acquired. The most recent acquisition was Gleamer in Mar 2026 by RadNet for $*****.Here are Heal Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 02, 2026 | Jun 28, 2023 | Series B | 9100 | |
Dec 05, 2025 | Dec 20, 2021 | Series A | 2974 | |
Mar 02, 2023 | Jul 30, 2020 | Series A | 1196 |
Team profile of Heal Capital
Heal Capital has a team of 7 members including 3 Partners and 1 Venture Partner located in Germany. Heal Capital's team sits on the board of 1 company.Here is a list of all team members in Heal Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Berlin | - | - | |
Partner | Berlin | PAIR Finance and FinLeap | ||
Partner | Berlin | - | ||
Venture Partner | Frankfurt | - | - |
Co-investors of Heal Capital
Over the past 6 years, 114 investors have co-invested in Heal Capital's portfolio companies. This includes funds and angels.
- Invested before Heal Capital: HERAN Partners, Redalpine and 41 others have invested in rounds before Heal Capital. There is 1 company where HERAN Partners has invested before Heal Capital and 1 company where Redalpine has invested before Heal Capital.
- Top Co-investors of Heal Capital: 60 investors entered a company along with Heal Capital. These include investors like Octopus Ventures (2 companies).
- Invested after Heal Capital: A total of 11 investors have invested in Heal Capital's portfolio after their investments. Top Investors include OTB Ventures (1 company), eCAPITAL (1 company) and One Peak (1 company).
Recent News related to Heal Capital
•
Dutch Healthtech Ditto Raises €7.6M To Expand AI Patient Support Across EuropeStartup Rise EU•May 12, 2026•Ditto Care, Rubio impact Ventures, Heal Capital
•
•
•
FormlyAI secures $2M to accelerate medical device certification with AITech Funding News•Sep 15, 2025•Massive, Formly.ai, Heal Capital, Gradient Ventures
•
Investments in the future: Heal Capital 2 invests in first start-upsPresse Portal•Jun 12, 2025•Heal Capital, MediShout, MEDICE Arzneimittel Pütter, Schwabe India
•
Heal Capital 2 invests in first start-ups in healthcareFinanzNachrichten•Jun 12, 2025•Heal Capital, MediShout, MEDICE Arzneimittel Pütter, Schwabe India
•
CGC Genomics Secures €1.7 Million in Pre-Seed Funding for Cancer Diagnosis AIStartup Rise EU•Apr 14, 2025•CANCER GENOMICS CONSORTIUM, Heal Capital, Becker Ventures, Springboard Health Angels and 2 others
•
Munich-based Hema.to Raises €3.6M in Fresh FundingStartup Rise EU•Feb 27, 2025•Hema.to, LUMO Labs, Bayern Kapital, Elaia and 2 others
•
Germany’s digital medtech startup Hema.to raises €3.6M to improve blood cancer diagnosis with AISilicon Canals•Feb 27, 2025•Hema.to, LUMO Labs, Bayern Kapital, Elaia and 2 others
•
DeepTech Apheris secures €20.1 million to transform life sciences data collaborationEU-Startups•Jan 02, 2025•Apheris, OTB Ventures, eCapital, Octopus Ventures and 1 other
